Skip to main content

The First and Only Mealtime Insulin Patch that Can Be Worn for Up to 7 Days

Now available in both 2U & 1U dosing

  • 1 patch replaces up to 21 injections over 7 days
  • Clinically shown to reduce A1C and improve time-in-range1–3
  • Click and dose in any situation
  • Deliver rapid-acting insulin under your skin using a tiny, flexible cannula
  • Injection-free
  • Comfortable to wear
  • Water-resistant
I'm Ready to Try CeQur Simplicity

You Can Simplify Your Mealtime Insulin with CeQur Simplicity

Convenient

One click delivers 2 units or 1 unit of rapid-acting insulin

Discreet

Compact, lightweight, and easily hidden under your clothes

Injection-Free

Soft cannula, less pain, no hassle6

See Why People are Breaking Up with Their Insulin Pen

Get Started Today!

Just answer a few questions to see if CeQur Simplicity may be right for you. It’s that simple.

Select an option*



* Indicates required fields

We respect the importance of your privacy and understand your health is a very personal and sensitive subject. CeQur Simplicity wants you to understand how it will use the information provided by you on this registration page. By clicking the “Submit” button above, you are indicating that CeQur Simplicity or its partners may use your information for program improvements, quality monitoring, data and analytics for commercial purposes, and future marketing communications. You also understand that you may opt out from receiving any future communications from CeQur Simplicity or its partners by clicking the “unsubscribe” link within any email you receive, or by calling 1-888-552-3787.

To better understand how CeQur Simplicity values your privacy, please see our Privacy Policy.

Reference
  1. Bergenstal RM, Peyrot M, Dreon DM, et al. Diabetes Technol Ther. (2019)
  2. Bergenstal R, et al.  J Diabetes Sci Technol. (2021).
  3. Ceriello A. Diabetes. (2005)
  4. Zraick V, et al. Poster presented at the American Diabetes Association’s 76th Scientific Sessions. Abstract. (2016).
  5. Isaacs D, et al. Clin Diabetes. (2023).
  6. Bergenstal R, Peyrot M, Dreon D, Aroda V, Bailey T, Brazg R, Frias J, Johnson M, Klonoff D, Kruger D, Ramtoola S, Rosenstock J, Serusclat P, Weinstock R, Naik R, Shearer D, Zraick V, Levy B on behalf of the Calibra Study Group. 2019. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. Diabetes Technology and Therapeutics 21 (5):1-13.